482 related articles for article (PubMed ID: 34899613)
1. Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.
Mohajer N; Du CY; Checkcinco C; Blumberg B
Front Endocrinol (Lausanne); 2021; 12():780888. PubMed ID: 34899613
[TBL] [Abstract][Full Text] [Related]
2. Role of Obesogens in the Pathogenesis of Obesity.
Shahnazaryan U; Wójcik M; Bednarczuk T; Kuryłowicz A
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438630
[TBL] [Abstract][Full Text] [Related]
3. Endocrine disrupters as obesogens.
Grün F; Blumberg B
Mol Cell Endocrinol; 2009 May; 304(1-2):19-29. PubMed ID: 19433244
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disruptors and obesity.
Heindel JJ; Newbold R; Schug TT
Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
[TBL] [Abstract][Full Text] [Related]
5. The new kids on the block: Emerging obesogens.
Chamorro-Garcia R; Veiga-Lopez A
Adv Pharmacol; 2021; 92():457-484. PubMed ID: 34452694
[TBL] [Abstract][Full Text] [Related]
6. Obesogens: an emerging threat to public health.
Janesick AS; Blumberg B
Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
[TBL] [Abstract][Full Text] [Related]
7. The obesogen tributyltin.
Grün F
Vitam Horm; 2014; 94():277-325. PubMed ID: 24388195
[TBL] [Abstract][Full Text] [Related]
8. Obesogens.
Grün F
Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):453-9. PubMed ID: 20689419
[TBL] [Abstract][Full Text] [Related]
9. Obesity II: Establishing causal links between chemical exposures and obesity.
Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
[TBL] [Abstract][Full Text] [Related]
10. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
Grün F; Blumberg B
Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
[TBL] [Abstract][Full Text] [Related]
11. Obesogenic endocrine disruptors and obesity: myths and truths.
Muscogiuri G; Barrea L; Laudisio D; Savastano S; Colao A
Arch Toxicol; 2017 Nov; 91(11):3469-3475. PubMed ID: 28975368
[TBL] [Abstract][Full Text] [Related]
12. Transgenerational effects of obesogens.
Lee MK; Blumberg B
Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):44-57. PubMed ID: 30801972
[TBL] [Abstract][Full Text] [Related]
13. Obesogens in Foods.
Kladnicka I; Bludovska M; Plavinova I; Muller L; Mullerova D
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625608
[TBL] [Abstract][Full Text] [Related]
14. Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.
Egusquiza RJ; Blumberg B
Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32067051
[TBL] [Abstract][Full Text] [Related]
15. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?
Le Magueresse-Battistoni B
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33333918
[TBL] [Abstract][Full Text] [Related]
16. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.
Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599
[TBL] [Abstract][Full Text] [Related]
17. Endocrine disruptive compounds and cardio-metabolic risk factors in children.
Khalil N; Chen A; Lee M
Curr Opin Pharmacol; 2014 Dec; 19():120-4. PubMed ID: 25306432
[TBL] [Abstract][Full Text] [Related]
18. Transgenerational inheritance of prenatal obesogen exposure.
Janesick AS; Shioda T; Blumberg B
Mol Cell Endocrinol; 2014 Dec; 398(1-2):31-5. PubMed ID: 25218215
[TBL] [Abstract][Full Text] [Related]
19. Obesogens, stem cells and the developmental programming of obesity.
Janesick A; Blumberg B
Int J Androl; 2012 Jun; 35(3):437-48. PubMed ID: 22372658
[TBL] [Abstract][Full Text] [Related]
20. Environmental Obesogens: Mechanisms and Controversies.
Heindel JJ; Blumberg B
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
